160 related articles for article (PubMed ID: 16697748)
1. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
2. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
3. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
4. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
5. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of gastric cancer using decision tree classification of mass spectral data.
Su Y; Shen J; Qian H; Ma H; Ji J; Ma H; Ma L; Zhang W; Meng L; Li Z; Wu J; Jin G; Zhang J; Shou C
Cancer Sci; 2007 Jan; 98(1):37-43. PubMed ID: 17052262
[TBL] [Abstract][Full Text] [Related]
7. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
[TBL] [Abstract][Full Text] [Related]
8. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
10. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
12. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins.
Kojima T; Yoshikawa K; Saga S; Yamada T; Kure S; Matsui T; Uemura T; Fujimitsu Y; Sakakibara M; Kodera Y; Kojima H
J Surg Res; 2009 Jul; 155(1):13-7. PubMed ID: 19394641
[TBL] [Abstract][Full Text] [Related]
13. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
14. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
[TBL] [Abstract][Full Text] [Related]
16. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry.
Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT
Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742
[TBL] [Abstract][Full Text] [Related]
17. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
18. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
[TBL] [Abstract][Full Text] [Related]
19. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
20. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]